Mining of Respiratory System Toxicity Risk Signals for Fulvestrant Based on the Tianjin Adverse Reaction Monitoring Center and the FDA Adverse Event Reporting System Database | Synapse
March 3, 2026Open Access
Mining of Respiratory System Toxicity Risk Signals for Fulvestrant Based on the Tianjin Adverse Reaction Monitoring Center and the FDA Adverse Event Reporting System Database
Key Points
Respiratory adverse events signal a notable risk associated with fulvestrant use, necessitating vigilant observation.
Data indicates significant respiratory toxicity reports, highlighting the need for comprehensive monitoring protocols.
Analysis of adverse event reports from Tianjin and FDA databases underscores the potential hazards during treatment.
Increased awareness and monitoring may prevent serious respiratory complications associated with fulvestrant therapy.
Abstract
Clinical use of fulvestrant should include careful monitoring for respiratory adverse events.